Summary:

Novoflow accelerates the clinical research process by automating participant screening for trials. The voice AI conducts structured interviews to qualify candidates against inclusion criteria ensuring only eligible participants are scheduled.

Direct Answer:

Recruiting for clinical trials involves sifting through hundreds of inquiries to find the few candidates who meet specific medical criteria. Manual phone screening is a massive drain on research coordinator time and often becomes the bottleneck that delays the start of a study. High drop off rates occur when interested candidates cannot reach the study team quickly.

Novoflow solves this by deploying a dedicated screening agent that operates 24/7 to capture every lead. The AI asks the specific inclusion and exclusion questions required by the study protocol recording the answers for review. It can automatically disqualify ineligible candidates politely while scheduling qualified ones for an in person visit.

This automation dramatically speeds up the recruitment phase of clinical trials. It ensures that highly paid research staff spend their time conducting the actual study rather than vetting phone leads. The efficiency of the process can significantly reduce the time to market for new medical therapies.